Skip to content
  • Who We Are
    • About Us
      • ISB Today
      • What is Systems Biology?
      • Our History
      • Contact ISB
    • People
      • Leadership
      • Board of Directors
      • Director Emeritus
      • Foundation Board
      • Faculty
      • Education Directors
      • Principal Scientists
      • Senior Research Scientists
      • Affiliate Faculty
      • Scientific Advisory Board
    • Labs
      • All Labs
    • Careers
      • Work At ISB
      • Faculty Development
      • Postdoctoral Fellowships
      • Grad Student Opportunities
      • Internships
  • What We Do
    • Research Areas
      • All Research Areas
      • Cancer
      • Health
      • Infectious Disease
      • Chronic Illness
      • Environment
    • Education and Training
      • Education Initiatives
      • Educator Resources
      • Student Programs
      • Courses and Symposia
    • Published Research
      • Publications
    • Open Source Software
      • Software and Downloads
    • Services
      • Olink® Services
      • Proteomics Services
  • News and Events
    • News
      • ISB News
    • Newsletter
      • Subscribe
    • Events
      • Upcoming Events
      • Events Archive
    • Media
      • Media Coverage
      • Press Releases
      • Media Inquiries
    • Social Media
      • LinkedIn
      • Bluesky
      • X
      • Instagram
      • Facebook
      • YouTube
  • Ways To Give
    • Ways To Give
      • How You Can Help
    • Giving Priority Areas
      • My Digital Gut
      • STEM Education
      • HPV+ Cancer
    • Team
      • Meet Us
    • Donate Now
      • Donate →
Donate
clear

Featured News

Drs. Wei Wei and Jim Heath

Posted: March 20, 2025

Cancer Press Release Heath Lab
Melanoma Starts Evading Treatment Within Hours – Here’s How to Stop It

Melanoma Starts Evading Treatment Within Hours – Here’s How to Stop It

ISB researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a promising new approach to improving treatment outcomes.

Melanoma Starts Evading Treatment Within Hours – Here’s How to Stop It
Melanoma Starts Evading Treatment Within Hours – Here’s How to Stop It

Posted: February 18, 2025

Health Press Release Gibbons Lab
Scientists Decode Diet From Stool DNA – No Questions Asked

Scientists Decode Diet From Stool DNA – No Questions Asked

ISB’s Gibbons Lab developed a breakthrough method that analyzes food-derived DNA in fecal metagenomes, allowing for data-driven diet tracking without the need for burdensome questionnaires.

Scientists Decode Diet From Stool DNA – No Questions Asked
Scientists Decode Diet From Stool DNA – No Questions Asked

More News (Wei Lab)

 
Wei

Posted: November 27, 2024

Cancer Events Wei Lab
ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever

ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever

Dr. Wei Wei has developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient. 

ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever
ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever
Wei Wei, PhD

Posted: July 10, 2024

People Wei Lab
Dr. Wei Wei Promoted to Associate Professor

Dr. Wei Wei Promoted to Associate Professor

Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

Dr. Wei Wei Promoted to Associate Professor
Dr. Wei Wei Promoted to Associate Professor
Wei Lab

Posted: July 16, 2021

Cancer Press Release Wei Lab
Add Fatty Acid to Taste: New Technology Reveals Single Cancer Cells Have Different Appetites for Fatty Acids

Add Fatty Acid to Taste: New Technology Reveals Single Cancer Cells Have Different Appetites for Fatty Acids

A recently developed method by the Wei Lab at Institute for Systems Biology (ISB) and University of California, Riverside provides new insights into cancer biology by allowing researchers to show how fatty acids are absorbed by single cells. This work was published in the Journal of the American Chemical Society.

Add Fatty Acid to Taste: New Technology Reveals Single Cancer Cells Have Different Appetites for Fatty Acids
Add Fatty Acid to Taste: New Technology Reveals Single Cancer Cells Have Different Appetites for Fatty Acids
ISB Assistant Professor Dr. Wei Wei

Posted: April 2, 2021

People Wei Lab
Andy Hill CARE Fund Awards $100,000 to ISB Assistant Professor Dr. Wei Wei 

Andy Hill CARE Fund Awards $100,000 to ISB Assistant Professor Dr. Wei Wei 

To advance research at the intersection of COVID-19 and cancer, The Andy Hill CARE Fund has awarded ISB Assistant Professor Dr. Wei Wei a $100,000 grant to study chronic lymphocytic leukemia (CLL), one of the most commonly diagnosed leukemias in the Western world that mainly affects older individuals.

Andy Hill CARE Fund Awards $100,000 to ISB Assistant Professor Dr. Wei Wei 
Andy Hill CARE Fund Awards $100,000 to ISB Assistant Professor Dr. Wei Wei 
Dr. Wei Wei and Dr. Xiaowei Yan

Posted: March 9, 2021

Cancer Press Release Wei Lab
A Better Way to Find Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients

A Better Way to Find Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients

Despite the aggressive nature of Non-Small Cell Lung Cancer (NSCLC), circulating tumor cells that lead to metastases often go undetected in the blood. ISB researchers in Dr. Wei Wei’s lab and their collaborators have developed a novel method to better detect these circulating cells.

A Better Way to Find Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients
A Better Way to Find Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients
Wei Wei

Posted: August 26, 2019

Cancer Wei Lab Early Detection and Diagnosis
New Diagnostic Method Predicts Therapy Response in Lung Cancer Patients

New Diagnostic Method Predicts Therapy Response in Lung Cancer Patients

By using single-cell analysis to measure metabolic activities in rare disseminated tumor cells taken from non-small cell lung cancer (NSCLC) patients, ISB researchers and their collaborators can accurately predict how patients will respond to various cancer therapies, and how treatments will impact a patient’s physiological performance and survival.

New Diagnostic Method Predicts Therapy Response in Lung Cancer Patients
New Diagnostic Method Predicts Therapy Response in Lung Cancer Patients
View All News

  • Who We Are
    • Work At ISB
    • People
  • What We Do
    • Research
    • Publications
  • News and Events
    • Media Inquiries
    • News
  • Services
    • Olink Services
    • Proteomics Services
  • Other
    • Sponsored Projects Resources
    • COI
ISB logo (1-color)
Donate Contact Us

Subscribe to Molecular Me, where we share news of our transformational research, devoted scientists and educators, upcoming events, and more.

© 2025 Institute for Systems Biology (ISB). All Rights Reserved
  • Login
  • Intranet
  • Purchase Terms
  • Terms of Service
  • Privacy Policy